Delayed immune-inflammatory response after hyaluronic acid filler application: a clinical case
- Autores: Ikonnikova E.V1,2, Kruglova L.S1,2
-
Afiliações:
- Central State Medical Academy
- Institute of Plastic Surgery and Cosmetology
- Edição: Volume 26, Nº 8 (2019)
- Páginas: 88-91
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/312464
- DOI: https://doi.org/10.18565/pharmateca.2019.8.88-91
- ID: 312464
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Background. Hyaluronic acid-based filler injections are one of the most popular ways to aesthetically correct age-related skin changes. Despite the high safety profile, various complications can occur in some cases. Description of the clinical case. The article presents a clinical case of a 45-year-old patient who admitted to the Department of Dermatology and Cosmetology of the Institute of Plastic Surgery and Cosmetology with complaints of recurrent edema of the middle third of the face and pain in the area of the nasolacrimal groove and cheeks, severe pigmentation in the periorbital region after the hyaluronic acid filler injection. The occurrence and treatment of a rare delayed immune-inflammatory response after the hyaluronic acid filler application is described in detail. Conclusion. This clinical case is of potential interest to cosmetologists, dermatologists, plastic surgeons, physiotherapists as an example of the diagnosis, prevention and treatment of such pathological conditions.
Texto integral
Sobre autores
E. Ikonnikova
Central State Medical Academy; Institute of Plastic Surgery and Cosmetology
Email: evikonnikova@bk.ru
L. Kruglova
Central State Medical Academy; Institute of Plastic Surgery and Cosmetology
Bibliografia
- American Society of Aesthetic Plastic Surgeons. Statistics. www.surgery.org/media/statistics. Accessed June, 2018.
- Narins R.S, Jewel! M., Rubin M., et al. Clinical conference: Management of rare events following dermal fillers. Focal necrosis and angry red bumps. Dermatol Surg. 2006;32:426-34. doi: 10.1111/j.1524-4725.2006.32086.x.
- Liu M.H., Beynet D.P, Gharavi N.M. Overview of Deep Dermal Fillers. Facial Plast. Surg. 2019;35(3):224-29. doi: 10.1055/s-0039-1688843
- De Boulle K. Management of complications after implantation of fillers. J Cosmet Dermatol. 2004;3:2-15. doi: 10.1111/j.1473-2130.2004.00058.x.
- Alijotas-Reig J., Fernandez-Figueras M.T., Puig L. Inflammatory, immune-mediated adverse reactions related to soft tissue dermal fillers. Semin Arthr Rheum. 2013;43(2):241-58. Doi: 10.1016/j. semarthrit.2013.02.001.
- Hirsch R., Stier M. Complications of soft tissue augmentation. J Drugs Dermatol. 2008; 7:841-45.
- Alijotas-Reig J., Garcia-Gimenez V, Schwartz S.J. Late-onset immune-mediated adverse effects related to polyalkylimide dermal fillers. Arch Dermatol. 2008;144:637-42. Doi: 10.1001/ archderm.144.5.637.
- Christensen L., Breiting V, Jansen M., et al. Adverse reactions to injectable soft tissue permanent fillers. Aesthet Plast Surg. 2005;29:34-48. doi: 10.1007/s00266-004-0113-6.
- Bellman B. Immediate and Delayed Fypersensitivity. Reactions to Restylane. Aesthet Surg J. 2005;25:489-91. Doi: 10.1016/j. asj.2005.07.007.
- Marusza W., Mlynarczyk G., Olszanski R., et al. Probable biofilm formation in the cheek as a a complication of soft tissue filler resulting from improper endodontic treatment of tooth 16. Int J Nanomed. 2012;7:1441-47. doi: 10.2147/IJN. S27994.
- Dumitrascu D.I., Georgescu A.V The management of biofilm formation after hyaluronic acid gel filler injections: a review. Clujul Med. 2013; 86(3):192-95.
- Dayan S.H., Arkins J.P., Brindise R. Soft tissue fillers and biofilms. Facial Plast Surg. 2011;1:23-8. doi: 10.1055/s-0030-1270415.
- Narins R.S., Dayan S.H., Brandt F.S., Baldwin E.K. Persistence and improvement of nasolabial fold correction with non-animal- stabilized hyaluronic acid 100,000 gel particles/ml filler on two retreatment schedules: results up to 18 months on two retreatment schedules. Dermatol Surg. 2008;34(Suppl. 1):S2-8. doi: 10.1111/j.1524-4725.2008.34236.x.